{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Xylènes : Questions médicales les plus fréquentes",
"headline": "Xylènes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Xylènes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Xylènes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dérivés du benzène",
"url": "https://questionsmedicales.fr/mesh/D001555",
"about": {
"@type": "MedicalCondition",
"name": "Dérivés du benzène",
"code": {
"@type": "MedicalCode",
"code": "D001555",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Xylènes",
"alternateName": "Xylenes",
"code": {
"@type": "MedicalCode",
"code": "D014992",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ryan P Lively",
"url": "https://questionsmedicales.fr/author/Ryan%20P%20Lively",
"affiliation": {
"@type": "Organization",
"name": "School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, 311 Ferst Drive NW, Atlanta, GA 30332, USA. ryan.lively@chbe.gatech.edu."
}
},
{
"@type": "Person",
"name": "Jing Li",
"url": "https://questionsmedicales.fr/author/Jing%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA."
}
},
{
"@type": "Person",
"name": "Xiao Zhang",
"url": "https://questionsmedicales.fr/author/Xiao%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "School of Energy and Environmental Engineering, Key Laboratory of Clean Energy Utilization and Pollutant Control in Tianjin, Hebei University of Technology, China."
}
},
{
"@type": "Person",
"name": "Yao Ma",
"url": "https://questionsmedicales.fr/author/Yao%20Ma",
"affiliation": {
"@type": "Organization",
"name": "School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, 311 Ferst Drive NW, Atlanta, GA 30332, USA. ryan.lively@chbe.gatech.edu."
}
},
{
"@type": "Person",
"name": "Jian Zhang",
"url": "https://questionsmedicales.fr/author/Jian%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Hoffmann Institute of Advanced Materials, Shenzhen Polytechnic, 7098 Liuxian Blvd., Nanshan District, Shenzhen, 518055, P. R. China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Methicillin-resistant Staphylococcus aureus-associated orbital cellulitis: a case series.",
"datePublished": "2023-04-07",
"url": "https://questionsmedicales.fr/article/37029211",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10792-023-02698-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mptx2 defends against peritoneal infection by methicillin-resistant staphylococcus aureus.",
"datePublished": "2022-05-21",
"url": "https://questionsmedicales.fr/article/35609377",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.intimp.2022.108856"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predictors of Methicillin-resistant Staphylococcus aureus infection in children with acute osteomyelitis.",
"datePublished": "2024-10-10",
"url": "https://questionsmedicales.fr/article/39390563",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13052-024-01780-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Prevalence and risk factors for methicillin-resistant Staphylococcus aureus infection in children].",
"datePublished": "2024-01-22",
"url": "https://questionsmedicales.fr/article/38245868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.37201/req/113.2023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36371648",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/phar.2741"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Xylènes",
"item": "https://questionsmedicales.fr/mesh/D014992"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Xylènes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Xylènes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Xylènes",
"description": "Comment diagnostiquer une intoxication aux xylènes ?\nQuels tests sont utilisés pour évaluer l'exposition aux xylènes ?\nQuels symptômes indiquent une exposition aux xylènes ?\nLes xylènes peuvent-ils être détectés dans l'air ?\nQuelle est la méthode de diagnostic la plus courante ?",
"url": "https://questionsmedicales.fr/mesh/D014992?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Xylènes",
"description": "Quels sont les symptômes d'une intoxication aiguë aux xylènes ?\nLes xylènes provoquent-ils des effets à long terme ?\nComment les xylènes affectent-ils le système nerveux ?\nLes irritations cutanées sont-elles liées aux xylènes ?\nQuels signes indiquent une exposition chronique aux xylènes ?",
"url": "https://questionsmedicales.fr/mesh/D014992?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Xylènes",
"description": "Comment prévenir l'exposition aux xylènes ?\nLes xylènes sont-ils présents dans des produits courants ?\nQuelles mesures de sécurité doivent être prises en milieu professionnel ?\nLes fumeurs sont-ils plus à risque d'exposition aux xylènes ?\nLes enfants sont-ils plus sensibles aux xylènes ?",
"url": "https://questionsmedicales.fr/mesh/D014992?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Xylènes",
"description": "Quel est le traitement principal en cas d'intoxication aux xylènes ?\nDes antidotes existent-ils pour les xylènes ?\nComment traiter les irritations cutanées causées par les xylènes ?\nLes soins médicaux sont-ils nécessaires pour une exposition aux xylènes ?\nQuels traitements sont utilisés pour les effets neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D014992?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Xylènes",
"description": "Quelles complications peuvent survenir après une exposition aux xylènes ?\nLes xylènes peuvent-ils causer des cancers ?\nComment les xylènes affectent-ils la fonction hépatique ?\nLes effets des xylènes sont-ils réversibles ?\nQuelles sont les conséquences d'une exposition chronique ?",
"url": "https://questionsmedicales.fr/mesh/D014992?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Xylènes",
"description": "Qui est le plus à risque d'exposition aux xylènes ?\nLes personnes vivant près d'industries sont-elles à risque ?\nLes femmes enceintes sont-elles plus vulnérables ?\nLes personnes ayant des antécédents médicaux sont-elles à risque ?\nLes fumeurs sont-ils plus exposés aux xylènes ?",
"url": "https://questionsmedicales.fr/mesh/D014992?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux xylènes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins pour mesurer les niveaux de xylènes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'exposition aux xylènes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter les xylènes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux xylènes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des vertiges et des irritations des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Les xylènes peuvent-ils être détectés dans l'air ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des échantillons d'air peuvent être analysés pour mesurer la concentration de xylènes."
}
},
{
"@type": "Question",
"name": "Quelle est la méthode de diagnostic la plus courante ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'interrogatoire clinique et l'examen physique sont essentiels pour le diagnostic initial."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication aiguë aux xylènes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements, des maux de tête et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les xylènes provoquent-ils des effets à long terme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des troubles neurologiques et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Comment les xylènes affectent-ils le système nerveux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des symptômes neurologiques tels que des vertiges et des troubles de la coordination."
}
},
{
"@type": "Question",
"name": "Les irritations cutanées sont-elles liées aux xylènes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le contact avec les xylènes peut causer des irritations cutanées et des dermatites."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une exposition chronique aux xylènes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles cognitifs, des maux de tête fréquents et des problèmes respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux xylènes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et travailler dans des zones bien ventilées."
}
},
{
"@type": "Question",
"name": "Les xylènes sont-ils présents dans des produits courants ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils se trouvent dans des produits comme les peintures, les vernis et les nettoyants."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité doivent être prises en milieu professionnel ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Mettre en place des protocoles de sécurité, des formations et des équipements de protection."
}
},
{
"@type": "Question",
"name": "Les fumeurs sont-ils plus à risque d'exposition aux xylènes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter la vulnérabilité aux effets nocifs des xylènes."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus sensibles aux xylènes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques en raison de leur développement."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal en cas d'intoxication aux xylènes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste à retirer la personne de l'exposition et à administrer de l'oxygène si nécessaire."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les xylènes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique et de soutien."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées causées par les xylènes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé de laver la zone affectée avec de l'eau et du savon, et d'appliquer une crème apaisante."
}
},
{
"@type": "Question",
"name": "Les soins médicaux sont-ils nécessaires pour une exposition aux xylènes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une évaluation médicale est recommandée pour surveiller les symptômes et les complications."
}
},
{
"@type": "Question",
"name": "Quels traitements sont utilisés pour les effets neurologiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements symptomatiques et des thérapies de réhabilitation peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition aux xylènes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des troubles respiratoires, neurologiques et des problèmes hépatiques."
}
},
{
"@type": "Question",
"name": "Les xylènes peuvent-ils causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien potentiel entre l'exposition prolongée aux xylènes et certains cancers."
}
},
{
"@type": "Question",
"name": "Comment les xylènes affectent-ils la fonction hépatique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des lésions hépatiques et des troubles de la fonction hépatique."
}
},
{
"@type": "Question",
"name": "Les effets des xylènes sont-ils réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains effets peuvent être réversibles, mais d'autres, notamment neurologiques, peuvent être permanents."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une exposition chronique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition chronique peut entraîner des troubles cognitifs, des problèmes respiratoires et des cancers."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition aux xylènes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique, la peinture et le nettoyage sont les plus à risque."
}
},
{
"@type": "Question",
"name": "Les personnes vivant près d'industries sont-elles à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être exposées à des niveaux plus élevés de xylènes dans l'air ambiant."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles plus vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition aux xylènes peut affecter le développement fœtal et la santé de la mère."
}
},
{
"@type": "Question",
"name": "Les personnes ayant des antécédents médicaux sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, celles ayant des problèmes respiratoires ou neurologiques préexistants sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "Les fumeurs sont-ils plus exposés aux xylènes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter l'absorption des xylènes et leurs effets nocifs."
}
}
]
}
]
}
In recent years, methicillin-resistant Staphylococcus aureus (MRSA) orbital cellulitis (OC) has drawn increasing clinical and public health concern. We present a case series of MRSA OC encountered at ...
A multi-centre retrospective case series investigating MRSA OC in Australia from 2013 to 2022. Patients of all ages were included....
Nine cases of culture-positive non-multi-resistant MRSA (nmMRSA) OC were identified at four tertiary institutions across Australia (7 male, 2 female). Mean age was 17.1 ± 16.7 years (range 13-days to ...
NMMRSA OC can follow an aggressive clinical course causing severe orbital and intracranial complications across a wide demographic. However, early recognition, initiation of targeted antibiotics and s...
Methicillin-resistant Staphylococcus aureus (MRSA) has an increasing prevalence of multi-drug resistance. There is an urgent need for developing novel approaches to combat MRSA infection. Mucosal pent...
This study aims to identify risk factors associated with Methicillin-resistant Staphylococcus aureus (MRSA) infection in children diagnosed with acute osteomyelitis (AO) and to elucidate the laborator...
We conducted a retrospective analysis involving 123 children with acute osteomyelitis treated at our hospital. Upon admission, we measured white blood cell (WBC) counts, C-reactive protein (CRP) level...
The MRSA group had a significantly higher average age compared to the non-MRSA group (P < 0.05). Notably, the incidence of suppurative arthritis was significantly lower in the MRSA group (P < 0.05). A...
In children newly admitted with acute osteomyelitis, a CRP level exceeding 73.23 µg/mL may indicate a high likelihood of MRSA infection. For children with AO who have been hospitalized for three days ...
The objectives of this work were to know the prevalence of methicillin-resistant S. aureus (MRSA) infections in the paediatric population of our health department, to describe the risk factors for inf...
A retrospective, descriptive and analytical study of infections produced by MRSA versus those produced by MSSA was carried out during the years 2014 to 2018. Risk factors for MRSA infection were studi...
162 patients with S. aureus infections were identified. Of these, 25 (15.4%) were MRSA. The highest percentages of MRSA infection occurred among children who required hospital admission (23.4%). In th...
Our results suggest the need to review empirical local treatment regimen using drugs active against MRSA in infections of probable staphylococcal origin admitted to the hospital, especially if they ha...
The preferred antibiotic salvage regimen for persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) is unclear. We sought to evaluate the effectiveness and safety of vancomycin plus...
Single-center, retrospective cohort study between January 1, 2016, and December 31, 2021....
State University of New York Upstate University Hospital, a 748-bed tertiary care, academic medical center in Syracuse, NY....
Adult patients were included if they had blood cultures positive for MRSA ≥72 h, received vancomycin monotherapy initially, and received vancomycin plus ceftaroline for ≥24 h. Patients were excluded i...
Patients were medically complex with a median Pitt bacteremia score of 3, 63.3% (19/30) were admitted to the intensive care unit, and 66.7% (20/30) had infective endocarditis. Vancomycin-associated ac...
Vancomycin plus ceftaroline may represent an effective and well-tolerated salvage regimen option for persistent MRSAB....
Staphylococcus aureus is a common germ in bacterial infections in children. The rate of methicillin-resistant S. aureus (MRSA) is increasing lately....
The main aim is to know the rate of positive cultures to MRSA in Spanish pediatric emergency departments. The secondary aims are to analyse the risk factors for MRSA isolation (patient origin, history...
Retrospective multicenter study (07/01/2017-06/30/2018) with review of patient histories with isolation of S. aureus in samples of any origin obtained in 8 pediatric emergency departments of the Infec...
During this period, S. aureus was detected in 403 patients (average age 75.8 ± 59.2 months; 54.8% male): 28.8% hospital-related infections (HRI) and 71.2% community-related infections (CRI). Overall, ...
The overall MRSA rate was one in 6 staphylococcal infections. Higher MRSA rates were detected in samples of suppurating skin injuries and in foreign children or in children with a history of previous ...
We aimed to determine the synergistic effects of ceftaroline (CPT) in combination with daptomycin (DAP), vancomycin (VAN), or linezolid (LNZ) against various methicillin-resistant Staphylococcus aureu...
MRSA strains randomly selected from 2014 to 2018 were studied. Checkerboard titration and in vitro time-kill analyses were used to determine the synergistic activities of the antibiotic combinations....
A total of 10 genetically distinct MRSA strains were included in this study. The checkerboard titration analysis revealed that the CPT-DAP, CPT-VAN, and CPT-LNZ combinations had a synergistic effect a...
The CPT-DAP combination showed better synergistic activity than the CPT-VAN and CPT-LNZ combinations against the enrolled MRSA strains. DAP, rather than VAN or LNZ, might be a better choice for CPT co...
The methicillin-resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) has a high negative predictive value (NPV). We aimed to understand if there was a difference in the NPV of the MR...
We performed a single-center, retrospective cohort study of adults with a positive respiratory culture and MRSA nasal PCR admitted to a surgical ICU from 2016 to 2019. Patients were stratified by surg...
We analyzed 61 patients: 42.6% (n = 26) ACS-ICU and 57.4% (n = 35) CVICU. There were no differences in age, comorbidities, prior MRSA infection, recent antibiotic use, immunocompromised status, or ren...
The MRSA nasal PCR screen has a high NPV for ruling out MRSA pneumonia in critically ill surgical patients. However, patients in the CVICU and patients hospitalized ≥5 d had a longer time to de-escala...
Severe infections of virulent methicillin-resistant Staphylococcus aureus (MRSA) are a serious health problem. The present study aimed to investigate clonal spread, virulence and antimicrobial resista...
Molecular identification and mecA gene detection were performed with PCR. Clonal relatedness was evaluated by RAPD PCR and MLST. MRSA epidemiology, virulence and resistance patterns were investigated ...
All 27 isolates were identified as S. aureus and were mecA positive, and all were susceptible to linezolid, tigecycline and vancomycin. The toxin genes hlg (in 92.6% of isolates), seb (77.8%), sei (77...
To the best of our knowledge, this study is the first describing the clonal spreading of Bulgarian MRSA and the association with their virulence and resistance determinants. Monitoring of MRSA epidemi...
Endoscopic endonasal approach (EEA) procedures are inherently contaminated due to direct access through the nasopharyngeal mucosa. The reported rate of postoperative meningitis in EEA procedures is 0....
All adult patients who underwent EEA resection at our institution from 2013 to 2021 were retrospectively reviewed. Patients with preoperative cerebrospinal fluid infections were excluded. Data includi...
Of 483 patients identified (mean age, 51 years; range, 18-90 years; 274 [56.7%] female), 80 (16.6%) had a positive preoperative methicillin-resistant Staphylococcus aureus (MRSA)/methicillin-sensitive...
Postoperative rates of meningitis after EEA surgery were not significantly changed based on MRSA/MSSA colonization status of the patient or preoperative decolonization. The utility of preoperative tes...